Table 1 Information on plants used in the present study
Species (family); Voucher numbera | Traditional uses | Parts used traditionally | Bioactive or potentially bioactive components | Bioactivity of crude extract |
|---|---|---|---|---|
Xanthosoma mafaffa (L.) Schott (Araceae); 18675/SRF/Cam | Bone disease (osteoporosis) [37] | Leaves and tubers | - | - |
Passiflora edulis Sims (Passifloraceae); 65104/HNC | Anxiety, insomnia and nervousnes, antifungal, anti-inflammatory, antihypertensive [38], gastric trouble [39], antioxidant, cancer [40] | Leaves, fruit, bark and roots | ionone-I, ionone-II, megastigma-5,8-dien-4–1, megastigma-5,8(Z)-diene-4–1, 4,4a-Epoxy-4, 4a-dihydroedulan, 3-hydroxyedulan, edulan-I, edulan-II, passifloric acid methyl ester [40] | Methanol extract : Sa, Sf, Bs, Ec, Pv and St [40] |
Moringa oleifera Lam. (Moringaceae); 49178/HNC | Dental caries, syphilis, typhoid, diarrhea, epilepsy, purgative, prostate cancer, water purification [41], fever, HIV-AIDS [42] | Leaves, flowers, seeds and barks | 4-(4’-O-acetyl-α-L-rhamnopyranosyloxy)benzylisothiocyanate, 4-(-L-rhamnopyranosyloxy)benzylisothiocyanate, niazimicin, pterygospermin, benzylisothiocyanate and 4-(α-L-rhamnopyranosyloxy)benzylglucosinolate [43] | Aqueous and ethanol extracts of seeds against Sa, Vc, Ec, Se, Lv and On [44] |